Rodrigues M, Fonseca A T, Salgado D, Vieira M R
Department of Nuclear Medicine, Instituto Português de Oncologia, Lisbon.
Nucl Med Commun. 1993 Dec;14(12):1050-60. doi: 10.1097/00006231-199312000-00002.
High-grade astrocytoma represents the most common primary malignant brain tumour in the adult, and is associated with high morbidity and mortality rates. The aim of this study was to investigate the prognostic value of 99Tcm-hexamethylpropyleneamine oxime (HMPAO) brain single photon emission computed tomography (SPECT) in predicting neurological function and tumour therapy response after surgical resection of astrocytoma. The correlation between 99Tcm-HMPAO studies and other noninvasive methods [computed tomography (CT), magnetic resonance imaging (MRI) and 201Tl (SPECT)] was evaluated. The clinical population included 21 patients with previous surgical debulking of astrocytoma. All patients were evaluated with 99Tcm-HMPAO brain SPECT. Seven patients, who suffered progressive clinical deterioration after radiotherapy, underwent dual-isotope SPECT imaging with 201Tl and 99Tcm-HMPAO. Neurological examinations and CT were performed in all patients. Magnetic resonance imaging was performed in seven patients. Prior to radiotherapy and/or chemotherapy, the patients with neurological improvement during the follow-up evaluation commonly showed less intense abnormal 99Tcm-HMPAO uptake than the patients without neurological improvement. In addition, after therapy none of the former patients had increased 99Tcm-HMPAO uptake. Most patients without neurological improvement had evidence of high focal uptake. Computed tomography and MRI usually demonstrated pathological contrast enhancement regardless of the presence or absence of improvement of neurological function. Foci of high 201Tl accumulation were observed on SPECT images in five patients. In four of these patients, the 99Tcm-HMPAO was greater than in normal brain, and in two patients the 99Tcm-HMPAO uptake was lower than in normal brain. One patient with decreased 99Tcm-HMPAO uptake in a medium-sized lesion had a normal 201Tl study. Our hypothesis that 99Tcm-HMPAO SPECT may be useful for providing prognostic information after surgical debulking of astrocytoma seems to be promising. Further studies are needed to document this new important role of 99Tcm-HMPAO SPECT.
高级别星形细胞瘤是成人中最常见的原发性恶性脑肿瘤,其发病率和死亡率都很高。本研究的目的是探讨99锝-六甲基丙烯胺肟(HMPAO)脑单光子发射计算机断层扫描(SPECT)在预测星形细胞瘤手术切除后神经功能和肿瘤治疗反应方面的预后价值。评估了99锝-HMPAO检查与其他非侵入性方法[计算机断层扫描(CT)、磁共振成像(MRI)和201铊(SPECT)]之间的相关性。临床研究对象包括21例曾接受过星形细胞瘤手术减瘤的患者。所有患者均接受了99锝-HMPAO脑SPECT检查。7例放疗后临床症状进行性恶化的患者接受了201铊和99锝-HMPAO双同位素SPECT成像检查。所有患者均进行了神经学检查和CT检查。7例患者进行了磁共振成像检查。在放疗和/或化疗前,随访评估中神经功能改善的患者,其99锝-HMPAO异常摄取强度通常低于神经功能未改善的患者。此外,治疗后,前者患者中无一例99锝-HMPAO摄取增加。大多数神经功能未改善的患者有高局灶性摄取的证据。无论神经功能是否改善,CT和MRI通常都显示出病理性对比增强。5例患者的SPECT图像上观察到201铊高聚集灶。其中4例患者的99锝-HMPAO高于正常脑,2例患者的99锝-HMPAO摄取低于正常脑。1例中等大小病灶99锝-HMPAO摄取降低的患者,其201铊检查结果正常。我们的假设,即99锝-HMPAO SPECT可能有助于提供星形细胞瘤手术减瘤后的预后信息,似乎很有前景。需要进一步研究来证实99锝-HMPAO SPECT的这一新的重要作用。